Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Madrigal Pharmaceuticals
MDGL
$11.7B
| $1.36M | ﹤0.01% |
17,111
-35,871
| -68% | -$3.1M |
|
2377
Vanguard Consumer Discretionary ETF
VCR
$6.11B
| $1.36M | ﹤0.01% |
4,400
-6,400
| -59% | -$2.03M |
|
2378
MP Materials
MP
$10.5B
| $1.36M | ﹤0.01% |
+42,300
| New | +$1.47M |
|
2379
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $1.36M | ﹤0.01% |
+13,300
| New | +$1.4M |
|
2380
Farmers & Merchants Bancorp
FMAO
$483M
| $1.36M | ﹤0.01% |
60,581
-36,498
| -38% | -$817K |
|
2381
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $1.35M | ﹤0.01% |
9,700
-3,800
| -28% | -$540K |
|
2382
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
| $1.35M | ﹤0.01% |
+42,700
| New | +$1.48M |
|
2383
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $1.35M | ﹤0.01% |
36,853
+8,453
| +30% | +$311K |
|
2384
Vanguard High Dividend Yield ETF
VYM
$84B
| $1.34M | ﹤0.01% |
+13,000
| New | +$1.37M |
|
|
ATTO
2385
DELISTED
Atento S.A.
ATTO
| $1.34M | ﹤0.01% |
47,523
+7,780
| +20% | +$200K |
|
2386
Matthews International
MATW
$725M
| $1.34M | ﹤0.01% |
38,553
-19,628
| -34% | -$674K |
|
2387
Talkspace
TALK
$871M
| $1.34M | ﹤0.01% |
+366,323
| New | +$2.01M |
|
|
OYST
2388
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $1.33M | ﹤0.01% |
+112,300
| New | +$1.64M |
|
2389
Passage Bio
PASG
$14.8M
| $1.33M | ﹤0.01% |
6,660
+3,445
| +107% | +$821K |
|
2390
Sprott Uranium Miners ETF
URNM
$2B
| $1.33M | ﹤0.01% |
+34,528
| New | +$1.12M |
|
2391
Artisan Partners
APAM
$2.99B
| $1.33M | ﹤0.01% |
27,100
-175,619
| -87% | -$8.86M |
|
|
DVD
2392
DELISTED
Dover Motorsports
DVD
| $1.31M | ﹤0.01% |
543,236
-50,786
| -9% | -$125K |
|
2393
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $1.31M | ﹤0.01% |
41,500
+15,000
| +57% | +$485K |
|
2394
RLI Corp
RLI
$5.85B
| $1.31M | ﹤0.01% |
26,200
+9,928
| +61% | +$528K |
|
2395
Minerva Neurosciences
NERV
$219M
| $1.31M | ﹤0.01% |
94,265
-30,966
| -25% | -$466K |
|
2396
Mustang Bio
MBIO
$4.5M
| $1.31M | ﹤0.01% |
650
+630
| +3,150% | +$1.35M |
|
2397
Merchants Bancorp
MBIN
$2.52B
| $1.31M | ﹤0.01% |
49,800
+12,000
| +32% | +$298K |
|
2398
Barnwell Industries
BRN
$13.9M
| $1.31M | ﹤0.01% |
432,168
-291,376
| -40% | -$708K |
|
2399
Bio-Techne
TECH
$11.3B
| $1.31M | ﹤0.01% |
10,800
-23,600
| -69% | -$2.87M |
|
|
CBIO
2400
Crescent Biopharma
CBIO
$637M
| $1.3M | ﹤0.01% |
5,961
-1,616
| -21% | -$342K |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.